SCHEMBL640294

SCHEMBL640294

COC(C)OCOc1ccccc1C=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.56
HPGD P15428 1/20 0.56
HTT P42858 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
PTGDR2 Q9Y5Y4 1/20 0.47
LMNA P02545 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
KMT2A Q03164 4/20 0.42
MEN1 O00255 2/20 0.42
RAD52 P43351 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TDP1 Q9NUW8 2/20 0.39
TLR2 O60603 1/20 0.39
ERN1 O75460 1/20 0.39
TLR1 Q15399 1/20 0.39
TLR6 Q9Y2C9 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11323988 0.81 ALDH1A1 (0.53) ALDH1A1HPGDHTTSMN1; SMN2PTGDR2
SCHEMBL11384810 0.81 ALDH1A1 (0.56) ALDH1A1HPGDHTTSMN1; SMN2PTGDR2
SCHEMBL4998800 0.81 ALDH1A1 (0.47) ALDH1A1HPGDHTTSMN1; SMN2LMNA
SCHEMBL1243967 0.80 ALDH1A1 (0.68) ALDH1A1HPGDHTTSMN1; SMN2PTGDR2
SCHEMBL3376912 0.80 ALDH1A1 (0.58) ALDH1A1HTTLMNACYP1A2CYP2C9
SCHEMBL1276592 0.79 ALDH1A1 (0.79) ALDH1A1HPGDHTTSMN1; SMN2PTGDR2
SCHEMBL30972130 0.79 ALDH1A1 (0.79) ALDH1A1HPGDHTTSMN1; SMN2PTGDR2
2-Methoxybenzaldehyde SCHEMBL5070004 0.78 ALDH1A1 (0.54) ALDH1A1HPGDHTTSMN1; SMN2LMNA
SCHEMBL5807282 0.77 CA1 (0.39) ALDH1A1HPGDHTTSMN1; SMN2LMNA
SCHEMBL4808585 0.76 ALDH1A1 (0.62) ALDH1A1HPGDHTTSMN1; SMN2PTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119647-B2 Fused pyrimidineone compounds as TRPV3 modulators GLENMARK PHARMACEUTICALS S.A. (CH) 2012-02-21 US disclosed